user Sign In

QYResearch Account

Manage your Account and Access Personalized Content.

Sign in

Create Account with us

Manage your Account and Access Personalized Content.

Sign Up
       
  
×

Global Cancer Supportive Care Industry Chain Research Report 2019

Published Date: 2019-02-10   |   Pages: 90   |   Tables: 103   | Report Id: 988253   | Hits: 11 |   Pharma & Healthcare



The cancer supportive care product market consists of drugs intended to prevent or treat the symptoms of cancer, and reduce the side effects of cancer treatments. Instead of extending a patient’s life expectancy, the emphasis is on improving overall quality of life.

With growing prevalence of cancer, the demand for cancer treatments, such as chemotherapy has also been consistently on the rise since the past decade. However, radiation therapy brings with it a host of side effects that are challenging for cancer patients to face while they undergo the course of treatment. While the cancer treatment realm is tremendously progressing, the incidences of side effects are increasing as well, which are addressed by cancer supportive care. The advent of technology in cancer supportive care has enabled to treat different signs and symptoms following the chemotherapy procedure, in addition to chemotherapy-induced vomiting, nausea, neutropenia, and anemia. The global market for cancer supportive care products is currently thriving at a sound pace and is anticipated to see steady growth over the next few years.

The high investment in the oncology segment and pharmaceutical industry in US and Canada, and the presence of several large vendors operating in US contribute to the growth of the palliative cancer care market in the Americas. Additionally, constant R&D activities in the oncology sector, strong economic condition, and huge investments in the healthcare segment further contribute to the market growth.

The global Cancer Supportive Care market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.

This report focuses on Cancer Supportive Care volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cancer Supportive Care market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.

At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:

Amgen

Helsinn Healthcare

Johnson &Johnson

Merck

F. Hoffmann-La Roche

GlaxoSmithKline

Novartis

TESARO

Teva Pharmaceutical Industries

Segment by Regions

North America

Europe

China

Japan

Segment by Type

Nonsteroidal Erythropoietin Stimulating Agents

Opioid Analgesics

Anti-Imflammatory Drugs

Anti-Infective Drugs

Bisphosphonates

Anti-Emetics Drugs

Monoclonal Antibodies

Granulocyte Colony Stimulating Factor

Segment by Application

Lung Cancer

Breast Cancer

Prostate Cancer

Liver Cancer

Bladder Cancer

Leukemia

Ovarian Cancer

Melanoma

Others

Licenses Type

Only one user can access the report
Multiple users can access the report

Why QYR

 Fastest report delivery service
 More than 10 years of vast experience
 Operational for 24 * 7 & 365 days
 In-depth and comprehensive analysis
 Excellent after sales support
 Owns large database

Need Help ?

QYR Clients

More Clients...